Free tool
FAERS Monitor: Bactocill In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050640 or its brand name (Bactocill In Plastic Container, Oxacillin Sodium). Reports on generic versions are filed under their own applications.
Reports
980
Serious
917
94% of reports
Hospitalization
524
Death reported
189
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective90
- acute kidney injury63
- drug reaction with eosinophilia and systemic symptoms54
- pyrexia49
- rash48
- drug interaction42
- off label use39
- staphylococcal infection35
- toxic epidermal necrolysis35
- pneumonia34
- renal failure33
- alanine aminotransferase increased31
- hypotension29
- condition aggravated28
- renal failure acute28
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 44 |
| 2005 | 27 |
| 2006 | 25 |
| 2007 | 30 |
| 2008 | 18 |
| 2009 | 30 |
| 2010 | 15 |
| 2011 | 37 |
| 2012 | 53 |
| 2013 | 16 |
| 2014 | 55 |
| 2015 | 53 |
| 2016 | 49 |
| 2017 | 57 |
| 2018 | 74 |
| 2019 | 48 |
| 2020 | 74 |
| 2021 | 59 |
| 2022 | 48 |
| 2023 | 46 |
| 2024 | 36 |
| 2025 | 47 |
| 2026 | 39 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| toxic epidermal necrolysisSignal | 35 | 49.6 | 35.8 | 1,615 |
| drug reaction with eosinophilia and systemic symptomsSignal | 54 | 45.1 | 34.8 | 2,284 |
| staphylococcal infectionSignal | 35 | 22.8 | 16.5 | 708 |
| renal failure acuteSignal | 28 | 14.2 | 9.8 | 330 |
| alanine aminotransferase increasedSignal | 31 | 10.8 | 7.7 | 268 |
| acute kidney injurySignal | 63 | 8.8 | 7.0 | 433 |
| drug interactionSignal | 42 | 5.7 | 4.2 | 159 |
| renal failureSignal | 33 | 5.3 | 3.8 | 113 |
| hypotensionSignal | 29 | 3.1 | 2.2 | 40 |
| pyrexiaSignal | 49 | 3.0 | 2.3 | 66 |
| rashSignal | 48 | 2.4 | 1.8 | 37 |
| pneumoniaSignal | 34 | 2.3 | 1.6 | 23 |
| condition aggravated | 28 | 2.0 | 1.4 | 13 |
| drug ineffective | 90 | 1.5 | 1.2 | 14 |
| off label use | 39 | 1.0 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.